Juned J Loharia Junaid M Alam Hassan A Abdelhadi Tamer F Marei
Neurosciences (Riyadh)
2015 Jan;20(1):55-60.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/25630783/
Antiphospholipid Syndrome / drug therapy Brain Ischemia / drug therapy Fibrinolytic Agents / therapeutic use Lupus Erythematosus, Systemic / complications Stroke / drug therapy Tissue Plasminogen Activator / therapeutic use
Antiphospholipid Syndrome / drug therapy Brain Ischemia / drug therapy Fibrinolytic Agents / therapeutic use Lupus Erythematosus, Systemic / complications Stroke / drug therapy Tissue Plasminogen Activator / therapeutic use Case Reports Adult Antiphospholipid Syndrome / etiology Brain Ischemia / diagnosis Brain Ischemia / pathology Female Humans Magnetic Resonance Angiography Middle Cerebral Artery / pathology Stroke / complications Stroke / diagnosis Thrombolytic Therapy / methods Treatment Outcome Fibrinolytic Agents Tissue Plasminogen Activator
PMC4727608
25630783
Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome. A rare stroke experience
2015